Requip (ropinirole) is the SECOND new drug for Parkinson's

    You now have a new option for treating Parkinson's.

    Requip (ropinirole) is the SECOND new drug for Parkinson's to hit the market this year.

    The first one, Mirapex (pramipexole), was approved in July.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote